세계의 디프테리아, 백일해 및 파상풍(DPT) 백신 시장 : 유형별, 연령층별, 최종 사용자별, 국가별, 지역별-산업 분석, 시장 규모, 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market End User was valued at USD 5,620.32 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine is a combination vaccine that provides protection against serious bacterial infections. These vaccines reduce the risk of infection and serious complications, especially in young children.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Market Dynamics

Increasing prevalence of DPT-related diseases among infant & children and rising awareness spread by government programs is expected to propel market demand

Increased efforts by governments and organizations to educate populations about the importance of vaccination is promoting market growth. Programs like WHO's Expanded Program on Immunization (EPI) and GAVI, the Vaccine Alliance, emphasize the need for widespread immunization against DPT-related diseases. Improved understanding of the risks of diphtheria, pertussis, and tetanus, particularly in children, drives demand. Also, the inclusion of the DPT vaccine in national immunization schedules boosts market demand. Many governments provide vaccines at little or no cost, making them accessible to underserved populations.

Infants and young children are particularly susceptible to DPT-related diseases. In the countries or regions with high birth rates, such as Africa and parts of Asia, the growing number of children under five drives the need for DPT vaccines. DPT is often combined with other vaccines like hepatitis B, polio for ease of administration, improving market penetration. Additionally, advancements in vaccine storage and distribution enhance accessibility in remote areas. Periodic pertussis outbreaks due to waning immunity have underscored the need for booster doses and high vaccination rates. Eradication and control efforts for diseases like diphtheria and pertussis prioritize DPT vaccines. Initiatives like maternal and neonatal tetanus (MNT) elimination programs support consistent vaccine uptake.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the DTaP vaccines segment was predicted to show maximum market share in the year 2023, mainly owing to WHO's recommendation.

Based on Age Group segmentation, the pediatrics segment was the leading Age Group segment in 2023, due to mandatory DTP vaccines made by WHO norms.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, mainly due to rising awareness among people about vaccination & programs by hospitals.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, due to the rise in the population across Asian countries.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Segmentation Analysis:

Global Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market is segmented on the basis of Type, Age Group, End User, and Region.

The market is divided into three categories based on the Type: DTaP vaccines, TD vaccines, and TDaP vaccines. The DTaP vaccines segment dominates the market. The growing need to prevent infectious disease prevalence is boosting segment growth.

The market is divided into two categories based on Age Group: adults and pediatrics. The pediatrics segment dominates the market. The increasing awareness among pediatrics groups about pre-vaccination programs is primarily supplementing segment growth.

The market is divided into three categories based on End User: hospitals, clinics, and others. The hospital segment is anticipated to grow at the fastest rate over the forecast period. The growing number of vaccination programs with WHO & UNICEF goals with maternal tetanus elimination, polios are expected to foster market demand.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, there is high vaccination coverage due to stringent public health mandates. Established healthcare infrastructure ensures widespread vaccine access. In Asia Pacific, rapidly growing due to high birth rates and large infant populations in countries like India, China, and Southeast Asia. Support from global organizations such as GAVI, WHO for immunization programs in low-income areas. India and China are major markets, both as vaccine consumers and producers.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Competitive Landscape:

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine market is characterized by intense competition among major pharmaceutical companies, continuous innovations, and strategic partnerships. The market is moving towards advanced combination vaccines like pentavalent and hexavalent formulations, which include additional antigens for diseases like hepatitis B and Hib. These innovations reduce the number of injections required for comprehensive immunization programs. Johnson & Johnson, GSK, Serum Institute, Bionet-Asia, and Meiji Holdings are some of the prominent players in the DPT vaccine space.

In 2023, Sanofi Pasteur launched Hexacima a six in a one immunization Vaccine in the U.S. market.

In 2022, Merck & Co. collaborated with Thermos to enhance vaccine storage and distribution technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET KEY PLAYERS

• GlaxoSmithKline (GSK)
• Sanofi Pasteur
• Merck & Co.
• Serum Institute of India
• Biological E Limited
• Pfizer Inc.
• Johnson & Johnson
• CSL Limited
• China National Pharmaceutical Group Corporation
• Bharat Biotech
• Novartis AG
• Panacea Biotec
• Valneva SE
• Bionet-Asia
• Meiji Holdings Co., Ltd.
• Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

• DTaP vaccines
• TD vaccines
• TDaP vaccines

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

• Adults
• Pediatrics

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

• Hospitals
• Clinics
• Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Type
  • 2.1.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Age Group
  • 2.1.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by End User
  • 2.1.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Country
  • 2.1.5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Region
• 2.2. Competitive Insights

3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Market Trends

• 3.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Opportunities
• 3.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Future Trends

4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Landscape

• 6.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
  • 7.1.2. DTaP vaccines
  • 7.1.3. TD vaccines
  • 7.1.4. TDaP vaccines

8. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Age Group

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
  • 8.1.2. Adults
  • 8.1.3. Paediatrics

9. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Clinics
  • 9.1.4. Others

10. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. GlaxoSmithKline (GSK)
  • 11.2.2. Sanofi Pasteur
  • 11.2.3. Merck & Co.
  • 11.2.4. Serum Institute of India
  • 11.2.5. Biological E Limited
  • 11.2.6. Pfizer Inc.
  • 11.2.7. Johnson & Johnson
  • 11.2.8. CSL Limited
  • 11.2.9. China National Pharmaceutical Group Corporation
  • 11.2.10. Bharat Biotech
  • 11.2.11. Novartis AG
  • 11.2.12. Panacea Biotec
  • 11.2.13. Valneva SE
  • 11.2.14. Bionet-Asia
  • 11.2.15. Meiji Holdings Co., Ltd.
  • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us